|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income | |||||
| Loss from discontinued operations, net of income taxes | |||||
| Income from continuing operations | |||||
| Adjustments to reconcile income from continuing operations to net cash provided by (used in) operating activities - continuing operations: | |||||
| Depreciation and amortization | |||||
| Impairment of goodwill | |||||
| Impairment, Long-Lived Asset, Held-for-Use | |||||
| Incremental charges on purchase accounting valuation of biological assets and inventory | |||||
| Net gain on sale of assets | |||||
| Gain (Loss) on Disposition of Stock in Subsidiary | |||||
| Unrealized Gain (Loss) on Investments | |||||
| Stock-based compensation expense | |||||
| Equity method earnings | |||||
| Net (gain) on disposal of businesses | |||||
| Amortization of debt discounts and debt issuance costs | |||||
| Deferred tax expense (benefit) | |||||
| Pension and other postretirement benefit plan expense | |||||
| Dividends received from equity method investees | |||||
| Fair value movement on contingent consideration | |||||
| Insured Event, Gain (Loss) | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Receivables, net of allowances | |||||
| Inventories | |||||
| Prepaids, other current assets and other assets | |||||
| Accounts payable, accrued liabilities and other liabilities | |||||
| Cash Provided by (Used in) Operating Activity, Continuing Operation | |||||
| Investing Activities | |||||
| Sales of assets | |||||
| Capital expenditures | |||||
| Proceeds from Sales of Business, Affiliate and Productive Assets | |||||
| Proceeds from sale of businesses, net of transaction costs and cash transferred | |||||
| Insurance proceeds | |||||
| Purchases of investments | |||||
| Sales (purchases) of unconsolidated affiliates | |||||
| Other | |||||
| Net Cash Provided by (Used in) Investing Activities, Continuing Operations, Total | |||||
| Financing Activities | |||||
| Proceeds from borrowings and overdrafts | |||||
| Repayments on borrowings and overdrafts and payment of debt refinancing fees | |||||
| Payment of debt issuance costs | |||||
| Dividends paid to shareholders | |||||
| Dividends paid to noncontrolling interests and other noncontrolling interest activity, net | |||||
| Other noncontrolling interest activity, net | |||||
| Proceeds from exercise of stock options | |||||
| Payments of contingent consideration | |||||
| Proceeds from Issuance Initial Public Offering | |||||
| Net cash used in financing activities - continuing operations | |||||
| Effect of foreign currency exchange rate changes on cash | |||||
| Net cash (used in) provided by operating activities - discontinued operations | |||||
| Net cash used in investing activities - discontinued operations | |||||
| Cash (used in) provided by discontinued operations, net | |||||
| (Decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period, including discontinued operations | |||||
| Cash and cash equivalents at end of period, including discontinued operations | |||||
| Supplemental cash flow information: | |||||
| Income tax payments, including discontinued operations, net of refunds | |||||
| Interest payments on borrowings | |||||
| Non-cash Investing and Financing Activities: | |||||
| Accrued property, plant and equipment | |||||
Loading...